Yuki Kageyama to Kinetics
This is a "connection" page, showing publications Yuki Kageyama has written about Kinetics.
Connection Strength
0.049
-
Early C-reactive protein kinetics predict survival of patients with advanced urothelial cancer treated with pembrolizumab. Cancer Immunol Immunother. 2021 Mar; 70(3):657-665.
Score: 0.036
-
Time course of gene expression after the injection of adenoviral vectors containing CTLA4IG gene. Transplant Proc. 2004 Oct; 36(8):2443-5.
Score: 0.012